Pitolisant tablet
HBS-101-CL-312
Phase 3 small_molecule active
Quick answer
Pitolisant tablet for Prader-Willi Syndrome is a Phase 3 program (small_molecule) at Harmony Biosciences Holdings with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Harmony Biosciences Holdings
- Indication
- Prader-Willi Syndrome
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active